Reinforcement processes in opiate addiction: A homeostatic model

Neurochemical Research

Volumn 21, Issue 11, 1996, Pages 1437-1454

  Schulteis, Gery ^a,b   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

addiction; drug dependence; drug withdrawal; neuroadaptation; Opiates; opponent process

Indexed keywords

COCAINE; DIAMORPHINE; DOPAMINE RECEPTOR; MORPHINE; OPIATE AGONIST; OPIATE RECEPTOR;

ANXIETY NEUROSIS; ARTICLE; COMPULSION; CONDITIONING; DEPRESSION; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; MODEL; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; VENTRAL TEGMENTUM;

EID: 0029857333     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532385     Document Type: Article

References (133)

1. Jaffe, J. H. 1990. Drug addiction and drug abuse. Pages 522-573, in Goodman Gilman, A., Rall, T. W., Nies, A. S., and Taylor, P. (eds.), The Pharmacological Basis of Therapeutics, Pergamon Press, New York.
2. Koob, G. F., Markou, A., Weiss, F., Schulteis, G. 1993. Opponent process and drug dependence: neurobiological mechanisms. Sem. Neurosci. 5:351-358.
3. Koob, G. F., Stinus, L., Le Moal, M., and Bloom, F. E. 1989. Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci. Biobehav. Rev. 13: 135-140.
4. Solomon, R. L. 1980. The opponent-process theory of acquired motivation. Am. Psychol. 35:691-712.
5. Di Chiara, G., and North, R. A. 1992. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:185-193.
6. Gawin, F. H., and Kleber, H. D. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 43:107-113.
7. Kalant, H. 1989. The nature of addiction: An analysis of the problem. Pages 1-28, in Goldstein, A. (ed.), Molecular and Cellular Aspects of the Drug Addictions, Springer-Verlag, New York.
8. Koob, G. F., and Bloom, F. E. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-23.
9. Robinson, T. E., and Berridge, K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:247-291.
10. Wise, R. A., 1988. The neurobiology of craving: Implications for the understanding and treatment of addiction. J. Abnormal Psychol. 97:118-132.
11. Stewart, J., De Wit, H., and Eikelboom, R. 1984. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91:251-268.
12. Wise, R. A., and Bozarth, M. A. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:469-492.
13. Schulteis, G., Markou, A., Cole, M., and Koob, G. F. 1995. Decreased brain reward produced by ethanol withdrawal. Proc. Nat. Acad. Sci. USA 92:5880-5884.
14. Deneau, G., Yanagita, T., and Seevers, M. H. 1969. Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30-48.
15. Jaffe, J. H., 1992. Opiates: Clinical aspects. Pages 186-194, in Lowinson, J. H., Ruiz, P., Millman, R. B., and Langrod, J. G. (eds.), Substance Abuse: A Comprehensive Textbook, Williams and Wilkins, Baltimore.
16. Koob, G. F., Pettit, H. O., Ettenberg, A., and Bloom, F. E. 1984. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 229: 481-486.
17. Yanagita, T. 1987. Prediction of abuse liability from animal studies. Pages 189-198, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
18. Haertzen C. A., and Hooks, N. T. Jr. 1969. Changes in personality (MMPI) and subjective experience (ARCI) throughout a cycle of addiction to morphine. J. Nerv. Mental Disease 148:606-614.
19. Goldberg, S. R., Spealman, R. D., and Kelleher, R. T. 1979. Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology 18:1015-1017.
20. Thompson, T., and Schuster, C. R. 1964. Morphine self-administration, food reinforced, and avoidance behaviors in rhesus monkey. Psychopharmacologia 5:87-94.
21. Weeks, J. R. 1962. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 138: 143-144.
22. Weeks, J. R., and Collins, R. J. 1964. Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia 6:267-279.
23. Jones, B. E., and Prada, J. A. 1973. Relapse to morphine use in dog. Psychopharmacologia 30:1-12.
24. Criswell, H. E., and Ridings, A. 1983. Intravenous self-administration of morphine by naive mice. Pharmacol. Biochem. Behav. 18:467-470.
25. Yokel, R. A. 1987. Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preference. Pages 1-33, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
26. Goldberg, S. R., Woods, J. H., and Schuster, C. R. 1971. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 176:464-471.
27. Koob, G. F. 1992. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-184.
28. Weeks, J. R., and Collins, R. J. 1976. Changes in morphine self-administration in rats induced by prostaglandin E and naloxone. Prostaglandins 12:11-19.
29. Kornetsky, C., and Esposito, R. U. 1979. Euphorigenic drugs: Effects on reward pathways of the brain. Fed. Proc. 38:2473-2476.
30. Esposito, R., and Kornetsky, C. 1977. Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science 195:189-191.
31. Esposito, R., and Kornetsky, C. 1978. Opioids and rewarding brain stimulation. Neurosci. Biobehav. Rev. 2:115-122.
32. Reid, L. D. 1987. Tests involving pressing for intracranial stimulation as an early procedure for screening likelihood of addiction of opioids and other drugs. Pages 391-421, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
33. Schroeder, R. L., Weinger, M. B., Vakassian, L., and Koob, G. F. 1991. Methylnaloxonium diffuses out of the brain more slowly than naloxone after direct intracerebral injection. Neurosci. Lett. 12:173-177.
34. Britt, M. D., and Wise, R. A. 1983. Ventral tegmental site of opiate reward: Antagonism by a hydrophilic opiate receptor blocker. Brain Res. 258:560-562.
35. Corrigall, W. A., and Vaccarino, F. J. 1988. Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol. Biochem. Behav. 30:443-450.
36. Vaccarino, F. J., Bloom, F. E., Koob, G. F. 1985. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86:37-42.
37. Negus, S. S., Henricksen, S. J., Mattox, A., Pasternak, G. W., Portoghese, P. S., Takemori, A. E., Weinger, M. B., and Koob, G. F. 1993. Effects of antagonists selective for mu-opioid, delta-opioid, and kappa-opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1245-1252.
38. Pettit, H. O., Ettenberg, A., Bloom, F. E., and Koob, G. F. 1984. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167-173.
39. Zito, G. Vickers, D. C., and Roberts, D. C. S. 1985. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 23:1029-1036.
40. Bozarth, M. A. 1987. Intracranial self-administration procedures for the assessment of drug reinforcement. Pages 173-187, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
41. Bozarth, M. A., and Wise, R. A. 1981. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 28:551-555.
42. Bozarth, M. A., and Wise, R. A. 1984. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516-517.
43. Olds, M. E. 1982. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237:429-440.
44. Goeders, N. E., Lane, J. D., and Smith, J. E. 1984. Intracranial self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20:451-455.
45. Olds, M. E. 1979. Hypothalamic substrate for the positive reinforcing properties of morphine in the rat. Brain Res. 168:351-360.
46. Britt, M. D., and Wise, R. A. 1981. Opiate rewarding action: independence of the cells of the lateral hypothalamus. Brain Res. 222:213-217.
47. Bals-Kubik, R., Ableitner, A., Herz, A., and Shippenberg, T. S. 1993. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:489-495.
48. Phillips, A. G., and LePiane, F. G. 1980. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol. Biochem. Behav. 12:965-968.
49. Shippenberg, T. S., Bals-Kubik, R., and Herz, A. 1993. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265: 53-59.
50. Alheid, G. F., and Heimer, L. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of the substantia inominata. Neuroscience 27:1-39.
51. Koob, G. F., Robledo, P., Markou, A., and Caine, S. B. 1993. The mesocorticolimbic circuit in drug dependence and reward - a role for the extended amygdala? Pages 289-309,in Kalivas, P. W., and Barnes, C. D. (eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton.
52. de Olmos, J. S., Alheid, G. F., and Beltramino, C. A. 1985. Amygdala. Pages 223-334, in Paxinos, G. (ed.), The Rat Nervous System, Academic Press, Sydney.
53. Hubner, C. B., and Koob, G. F. 1990. The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res. 508:20-29.
54. Koob, G. F., and Swerdlow, N. R. 1988. Functional output of the mesolimbic dopamine system. Ann. N. Y. Acad. Sci. 537:216-227.
55. Bechara, A., and van der Kooy, D. 1989. The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J. Neurosci. 9:3400-3409.
56. Himmelsbach, C. K. 1943. Symposium: can the euphoric, analgetic, and physical dependence effects of drugs be separated? IV. With reference to physical dependence. Fed. Proc. 2:201-203.
57. Lindesmith, A. R. 1968. Addiction and Opiates, Aldine Publishing Co., Chicago.
58. Young, A. M., and Goudie, A. J. 1995. Adaptive processes regulating tolerance to the behavioral effects of drugs. Pages 733-742 in Bloom, F. E., and Kupfer, D. J. (eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York.
59. Baker, T. B., and Tiffany, S. T. 1985. Morphine tolerance as habituation. Psychol. Rev. 92:78-108.
60. Wagner, A. R. 1976. Priming in STM: An information processing mechanism for self-generated or retrieval-generated depression in performance. Pages 95-128, in Tighe, T. J., and Leaton, R. N. (eds.), Habituation: Perspectives from child development, animal behavior, and neurophysiology. Lawrence Erlbaum, Hillsdale, NJ.
61. Siegel, S. 1975. Evidence from rats that morphine tolerance is a learned response. J. Comp. Physiol. Psychol. 89:498-506.
62. Poulos, C. X., and Cappell, H. 1991. Homeostatic theory of drug tolerance: A general model of physiological adaptation. Psychol. Rev. 98:390-408.
63. Maldonado, R., Stinus, L., Koob, G. F. 1996. Molecular Mechanisms of Opiate Withdrawal. Springer, New York.
64. Lett, B. T. 1989. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98:357-362.
65. Meyer, R. E., and Mirin, S. M. 1979. The Heroin Stimulus: Implications for a Theory of Addiction, Plenum Press, New York.
66. McAuliffe, W. E., and Gordon, R. A. 1974. A test of Lindesmith's theory of addiction: The frequency of euphoria among long-term addicts. Am. J. Sociol. 79:795-840.
67. Young, A. M., Sannerud, C. A., Steigerwald, E. S., Doty, M. D., Lipinski, W. J., and Tetrick, L. E. 1991. Tolerance to morphine stimulus control: role of morphine maintenance dose. Psychopharmacology 1023:59-67.
68. Shippenberg, T. S., Emmett-Oglesby, M. W., Ayesta, F. J., and Herz, A. 1988. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology 96:110-115.
69. Henningfield, J. E., Johnson, R. E., and Jasinski, D. R. 1987. Clinical procedures for the assessment of abuse potential. Pages 573-590, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
70. Adams, J. U., and Holtzman S. G. 1990. Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology 100:451-458.
71. Gellert V. F., and Sparber, S. B. 1977. A comparison of naloxone effects upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J. Pharmacol. Exp. Ther. 201:44-54.
72. Higgins, G. A., and Sellers, E. M. 1994. Antagonist-precipitated opioid withdrawal in rats: Evidence for dissociations between physical and motivational signs. Pharmacol. Biochem. Behav. 48: 1-8.
73. Koob, G. F., Wall, T. L., and Bloom, F. E. 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530-534.
74. Schulteis, G., Markou, A., Gold, L. H., Stinus, L., and Koob, G. F. 1994. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271:1391-1398.
75. Brady, L. S., and Holtzman, S. G. 1981. Locomotor activity in morphine-dependent and post-dependent rats. Pharmacol. Biochem. Behav. 14:361-370.
76. Hand, T. H., Koob, G. F., Stinus, L., and Le Moal, M. 1988. Aversive properties of opioid receptor blockade are centrally mediated and are potentiated by previous exposure to opiates. Brain Res. 474:364-368.
77. Mucha, R. F. 1987. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res. 418:214-220.
78. Stinus, L., Le Moal, M., and Koob, G. F. 1990. The nucleus accumbens and amygdala as possible substrates for the aversive stimulus effects of opiate withdrawal. Neurosci. 37:767-773.
79. Schaefer, G. J., and Michael, R. P. 1986. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol. Biochem. Behav. 25: 1263-1269.
80. Schulteis, G., Markou, A., Yackey, M., and Koob, G. F. 1994. Motivational consequences of naloxone-precipitated opiate withdrawal. NIDA Res. Monogr. 141 (vol 2): 90.
81. Emmett-Oglesby, M. W., Mathis, D. A., Moon, R. T. Y., and Lal, H. 1990. Animal models of drug withdrawal symptoms. Psychopharmacology 101:292-309.
82. Gauvin, D. V., and Holloway, F. A. 1991. Cue dimensionality in the 3-choice pentylene-tetrazole-saline-chlordiazepoxide discrimination task. Behav. Pharmacol. 2:417-428.
83. Goldberg, S. R. 1976. Stimuli associated with drug injections as events that control behavior. Pharmacol. Rev. 27:325-340.
84. Carrera, M. R. A., Schulteis, G., and Koob, G. F. 1995. Increased sensitivity to naloxone on heroin self-administration in dependent rats. Soc. Neurosci. Abstr. 21:725.
85. Azorlosa, J. L., Stitzer, M. L., and Greenwald, M. K. 1994. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history. Psychopharmacology 114:71-80.
86. Bickel, W. K., Stitzer, M. L., Liebson, I. A., and Bigelow, G. E. 1988. Acute physical dependence in man: Effects of naloxone after brief morphine exposure. J. Pharmacol. Exp. Ther. 244:126-132.
87. Heishman, S. J., Stitzer, M. L., Bigelow, G. E., and Liebson, I. A. 1989. Acute opioid physical dependence in postaddict humans: Naloxone dose effects after brief morphine exposure. J. Pharmacol. Exp. Ther. 248:127-134.
88. Heishman, S. J., Stitzer, M. L., Bigelow, G. E., and Liebson, I. A. 1989. Acute opioid physical dependence in humans: Effects of varying the morphine-naloxone interval. I. J. Pharmacol. Exp. Ther. 250:485-491.
89. Jones, R. T. 1980. Dependence in non-addict humans after a single dose of morphine. Pages 557-560, in Way, E. L. (ed.), Endogenous and Exogenous Opiate Agonists and Antagonists. Pergamon Press, New York.
90. Kirby, K. C., and Stitzer, M. L. 1993. Opioid physical dependence development in humans: effect of time between agonist pretreatments. Psychopharmacology 112:511-517.
91. Kirby, K. C., Stitzer, M. L., and Heishman, S. J. 1990. Acute opioid physical dependence in humans: Effect of varying the morphine-naloxone interval II. J. Pharmacol. Exp. Ther. 256:730-737.
92. Adams, J. U., and Holtzman, S. G. 1990. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J. Pharmacol. Exp. Ther. 253:483-489.
93. Meyer, D. R., and Sparber, S. B. 1977. Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine. Life. Sci. 21:1087-1094.
94. Schulteis, G., Heyser, C. J., and Koob, G. F. in press. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: Potentiation with a second morphine treatment.
95. Easterling, K. W., and Holtzman, S. G. 1995. Intracranial self-stimulation (ICSS): sensitization to an opioid antagonist following chronic agonist pretreatment in rats. Soc. Neurosci. Abstr. 21:721.
96. Young, A. M. 1986. Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. Psychopharmacology 88:201-208.
97. Schulteis, G., Heyser, C. J., and Koob, G. F. 1995. Acute dependence on opiates: Progressive increase in severity with long intervals between successive morphine treatments. Soc. Neurosci. Abstr. 21:723.
98. Council Reports 1972. Treatment of morphine-type dependence by withdrawal methods. J. Am. Med. Assoc. 219:1611-1615.
99. Fraser, H. F., and Isbell, H. 1960. Human pharmacology and addiction liabilities of phenazocine and levophenalcylmorphan. Bull. Narcotics 12:15-23.
100. Blasig, J., Herz, A., Reinhold, K., and Zieglgansberger, S. 1973. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38.
101. Gellert, V. F., and Holtzman, S. G. 1978. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J. Pharmacol. Exp. Ther. 205:536-546.
102. Wei, E., Loh, H. H., and Way, E. L. 1973. Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 184:398-403.
103. Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., and Watson, S. J. 1988. Anatomy of CNS opioid receptors. Trends Neu-rosci. 11:308-314.
104. Pasternak, G. W. 1988. The Opiate Receptors, The Humana Press, New York.
105. Koob, G. F., Maldonado, R., and Stinus, L. 1992. Neural substrates of opiate withdrawal. Trends Neurosci. 15:186-191.
106. Maldonado, R., Stinus, L., Gold, L. H., and Koob, G. F. 1992. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol Exp. Ther. 261: 669-677.
107. Franz, D. N., Hare, B. D., and McCloskey, K. L. 1982. Spinal sympathetic neurons: possible sites of opiate withdrawal suppression by clonidine. Science 215:1643-1645.
108. Harris, G. C., and Aston-Jones, G. 1994. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155-157.
109. Schulteis, G., Koob GF (1994). Dark side of drug dependence. Nature 371:108.
110. Cheney, D. L., and Goldstein, A. 1971. Tolerance to opioid narcotics: Time course and reversibility of physical dependence in mice. Nature 232:477-478.
111. Jacob, J. J., and Michaud, G. M. 1974. Acute physical dependence in the waking dog after a single low dose of morphine. Psychol. Med. 4:27-273.
112. Kosersky, D. S., Harris, R. A., and Harris, L. S. 1974. Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Eur. J. Pharmacol. 26:122-124.
113. Krystal, J. H., and Redmond, D. E. Jr. 1983. A preliminary description of acute physical dependence on morphine in the vervet monkey. Pharmacol. Biochem. Behav. 18:289-291.
114. Martin, W. R., and Eades, C. G. 1964. A comparison between acute and chronic physical dependence in the chronic spinal dog. J. Pharmacol. Exp. Ther. 146:385-394.
115. Ramabadran, K. 1983. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine. Life Sci. 33 (Suppl 1):385-388.
116. Wikler, A. Recent progress in research on the neurophysiological basis of morphine addiction. Am. J. Psychiatry 105:328-338.
117. Davis, W. M., and Smith, S. G. 1987. Conditioned reinforcement as a measure of the rewarding properties of drugs. Pages 199-209, in Bozarth, M. A., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York.
118. Childress, A. R., Ehrman, R., Rohsenow, D. J., Robbins, S. J., and O'Brien, C. P. 1992. Classically conditioned factors in drug dependence. Pages 56-69, in Lowinson, J. H., Ruiz, P., Millman, R. B., and Langrod, J. G. (eds.), Substance Abuse: A Comprehensive Textbook, Williams and Wilkins, Baltimore.
119. Wilder, A. 1973. Dynamics of drug dependence: Implications of a conditioning theory of research and treatment. Arch. Gen. Psychiatry 28:611-616.
120. O'Brien, C. P., Greenstein, R., Ternes, J., McLellan, T., and Grabowski, J. 1979. Unreinforced self-injections: effects of rituals and outcome in heroin addicts. NIDA Res. Monogr. 27:275-281.
121. Baldwin, H. A., and Koob, G. F. 1993. Rapid induction of conditioned opiate withdrawal. Neuropsychopharmacology 8:15-21.
122. Goodwin, D. W. 1992. Alcohol: Clinical Aspects. Pages 144-151, in: Lowinson, J. H., Ruiz, P., Millman, R. B., and Langrod, J. G. (eds.), Substance Abuse: A Comprehensive Textbook, Williams and Wilkins, Baltimore.
123. Mendelson, J. H., and Mello, N. K. 1979. Biological concommitants of alcoholism. N. Engl. J. Med. 301:912-921.
124. File, S. E., Baldwin, H. A., and Hitchcott, P. K. 1989. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology 98:252-264.
125. Rassnick, S., Heinrichs, S. C., Britton, K. T., and Koob, G. F. 1993. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:25-32.
126. Merlo-Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G. F., and Weiss, F. 1995. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15:5439-5447.
127. Richter R., and Weiss, F. submitted. In vivo CRF release in rat amygdala is increased during withdrawal after chronic cocaine self-administration with unlimited access.
128. Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., and Stinus, L. 1995. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol., 6:74-80.
129. Kokkinidis, L., and McCarter, B. D. 1990. Postcocaine depression and sensitization of brain stimulation reward: analysis of reinforcement and performance effects. Pharmacol. Biochem. Behav. 36:463-471.
130. Markou, A. and Koob, G. F. 1991. Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
131. Weiss, F., Markou, A., Lorang, M. T., and Koob, G. F. 1992. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 593:314-318.
132. Weiss, F., Parsons, L. H., Schulteis, G., Hyytia, P., Lorang, M. T., Bloom, F. E., and Koob, G. F. 1996. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and serotonin release in dependent rats. J. Neurosci. in press.
133. Koob, G. F. 1996. Drug addiction: The Yin and Yang of hedonic homeostasis. Neuron 16:893-896.